U.S. Silica Holdings, Inc. (NYSE:SLCA)
U.S. Silica Holdings, Inc. (NYSE:SLCA) represented a move of 0.07 percent or $0.49 per share and closed its previous day trading session at $14.2. 2.01 Million Shares were traded in the last trading session with an Average Volume of 2.81 Million Shares. The stock currently has a Market Capitalization of 1.14 Billion.
U.S. Silica Holdings, Inc. is a producer of industrial minerals, including sand proppants, whole grain silica, ground silica, fine ground silica, calcined kaolin clay and aplite clay. The company also operates as a research and development specialist for customized products and solutions. The industries and applications served by U.S. Silica includes oil and gas, glass, chemicals, foundry, building products, fillers and extenders, recreation, industrial filtration and treatment, and testing and analysis. U.S. Silica Holdings, Inc. is headquartered in Frederick, Maryland.
The stock traded between $12.89 and $38.70 over 1-Year time period showing its price to sales ratio of 0.72. U.S. Silica Holdings, Inc. (NYSE:SLCA) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-12.89 and 200-Day Simple Moving Average of $-40.93. Its Price to Free Cash Flow is 3.94 and Price to Book of 0.8.
Analyst’s recommended the stock as 2.4 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, U.S. Silica Holdings, Inc. (NYSE:SLCA) reported its Actual EPS of $0.44/share. The analysts offering Earnings Estimates for the company were believing that U.S. Silica Holdings, Inc. could bring EPS of $0.59/share. The difference between Actual EPS and Estimated EPS was -0.15 Percent. Thus showing an Earnings Surprise of -25.4 Percent.
InspireMD Inc. (NYSE:NSPR)
In the last trading session, InspireMD Inc. (NYSE:NSPR) added its value by -2.91% closing at the price of $0.2. The stock currently has market capitalization of 8.25 Million, with average volume of 4.59 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently InspireMD Inc. (NYSE:NSPR) is showing beta of 1.99. This particular value of beta suggests that InspireMD Inc. (NYSE:NSPR) has historically moved 199% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for InspireMD Inc. (NYSE:NSPR) is at $-57.85.
The stock currently has RSI of 38.8. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company’s initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.
InspireMD Inc. (NYSE:NSPR) topped its 52-week high price of $11.200 on 01/09/18 and 52-Week Low Price of $ 0.160 on 09/19/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 10.40% and monthly volatility of 9.18% respectively.